17 Non-controlling interests
|
|
2020 |
|
2019 |
||||||
|
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
% of non-controlling interest |
|
25% |
|
25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 January |
|
35 |
|
25 |
|
44 |
|
104 |
|
33 |
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
- Share of profit / charged to income statement |
|
2 |
|
(2) |
|
2 |
|
2 |
|
6 |
- Acquisitions |
|
- |
|
(1) |
|
- |
|
(1) |
|
57 |
- Other consolidation changes |
|
- |
|
- |
|
(10) |
|
(10) |
|
9 |
- Capital payments |
|
- |
|
- |
|
3 |
|
3 |
|
1 |
- Dividend paid |
|
(1) |
|
- |
|
(5) |
|
(6) |
|
(4) |
- Exchange differences |
|
(1) |
|
(1) |
|
(2) |
|
(4) |
|
2 |
Total changes |
|
- |
|
(4) |
|
(12) |
|
(16) |
|
71 |
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December |
|
35 |
|
21 |
|
32 |
|
88 |
|
104 |
‘Other consolidation changes’ relates mainly to the increase of DSM’s share in Zhejiang DSM Zhongken Biotechnology Co., Ltd. from 60% to 100%.
|
|
2020 |
|
2019 |
||||||
|
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
61 |
|
23 |
|
33 |
|
117 |
|
130 |
Property, plant and equipment |
|
44 |
|
102 |
|
174 |
|
320 |
|
283 |
Other non-current assets |
|
- |
|
23 |
|
33 |
|
56 |
|
57 |
Inventories |
|
36 |
|
11 |
|
23 |
|
70 |
|
76 |
Receivables |
|
22 |
|
33 |
|
55 |
|
110 |
|
99 |
Cash and cash equivalents |
|
3 |
|
1 |
|
45 |
|
49 |
|
41 |
Total assets |
|
166 |
|
193 |
|
363 |
|
722 |
|
686 |
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
Provisions (non-current) |
|
14 |
|
- |
|
2 |
|
16 |
|
19 |
Borrowings (non-current) |
|
1 |
|
78 |
|
31 |
|
110 |
|
64 |
Other non-current liabilities |
|
- |
|
2 |
|
15 |
|
17 |
|
19 |
Borrowings and derivatives (current) |
|
- |
|
- |
|
100 |
|
100 |
|
75 |
Other current liabilities |
|
9 |
|
29 |
|
98 |
|
136 |
|
131 |
Total liabilities |
|
24 |
|
109 |
|
246 |
|
379 |
|
308 |
|
|
|
|
|
|
|
|
|
|
|
Net assets (100% basis) |
|
142 |
|
84 |
|
117 |
|
343 |
|
378 |
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
59 |
|
6 |
|
141 |
|
206 |
|
220 |
Net profit for the year |
|
(9) |
|
9 |
|
12 |
|
12 |
|
16 |
Cash provided by / (used in) operating activities |
|
(23) |
|
20 |
|
(26) |
|
(29) |
|
(55) |